Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology PR Newswire Sep 25, 2024 12:00pm
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs GlobeNewswire Sep 20, 2024 1:00pm
Galmed Announces an Expansion of its Activities to Cancer and major Cardiometabolic Diseases PR Newswire Sep 19, 2024 11:00am